ecteinascidin 743 has been researched along with Spinal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reichardt, P | 1 |
| Contreras Ibáñez, JA; Díaz Gómez, L; Navas García, N | 1 |
2 other study(ies) available for ecteinascidin 743 and Spinal Neoplasms
| Article | Year |
|---|---|
Uncertainties that threaten the benefit/risk balance in early treatment lines for advanced or metastatic soft tissue sarcoma.
Topics: Aged, 80 and over; Chemoradiotherapy; Disease Progression; Fatal Outcome; Humans; Leiomyosarcoma; Lumbar Vertebrae; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Risk Assessment; Spinal Neoplasms; Trabectedin | 2021 |
Mestastatic gastric cancer from malignant fibrous histiocytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dioxoles; Docetaxel; Epirubicin; Fatal Outcome; Gemcitabine; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Lung Neoplasms; Male; Soft Tissue Neoplasms; Spinal Neoplasms; Stomach Neoplasms; Taxoids; Tetrahydroisoquinolines; Thigh; Thoracic Vertebrae; Trabectedin | 2011 |